Insurance

The update of the Urban Institute’s 2015 analysis suggests that the nation continues to be on track to spend much less on healthcare over the next several years than was projected by CMS in late 2010.

A study presented at the annual meeting of the American Society of Clinical Oncology by a group from Israel that evaluated the price trend of 30 anticancer agents following their launch, found that prices may increase by as much as 44% even after adjusting for inflation.

The transactions were announced a year ago right after a Supreme Court decision that left subsidies for the federal health exchange intact.

A point of care medication delivery system improves medication adherence to cardiovascular medications without increasing costs.

The most recent Kaiser Health Tracking Poll was conducted during an exceptionally violent week. Concerns about terrorism and gun policy outranked jobs and the economy and healthcare as voter priorities.

Although the term "accountable care organization" (ACO) may not be here to stay, value-based organizations are here to stay based on the direction CMS is headed, said Jeb Dunkelberger, vice president of accountable care services at McKesson and clinical & commercial operations at ACO Partner.

The top stories in managed care this week included coverage of JAMA’s special issue on healthcare transformation under the ACA, changes in the proposed 2017 Physician Fee Schedule promoting value-based care, and more.